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Introduction 
Glaucoma 
Glaucoma, a type of optic neuropathy, refers to a group of neurodegenerative 
diseases that cause retinal ganglion cell death and changes in the optic nerve resulting in 
visual defects and eventually total blindness if left untreated. It is the leading cause of 
irreversible blindness worldwide with an estimated 67 million people in 2000 suffering 
from bilateral blindness due to glaucoma (Coleman 1999). Most treatment options 
available to the estimated 67 million glaucoma sufferers worldwide focus on reducing 
intraocular pressure, with varying degrees of effectiveness depending on the individual. 
The damage caused by glaucoma before detection, however, is irreversible and treatment 
focuses simply on preventing further vision loss. Unfortunately, for some treatment is 
never particularly effective and vision loss persists unabated. (Coleman,1999). There is 
currently little understanding of the disease process of glaucoma, and how elevated levels 
of intraocular pressure are related to the characteristic retinal ganglion cell death and 
optic nerve changes (See figure 1). Additionally, it has been observed that elevated 
intraocular pressure is not always necessary or sufficient for development of the disease. 
Some individuals with significantly elevated intraocular pressure never develop 
glaucoma, while others with normal intraocular pressure have been observed to develop 
the disease (Ray 2003). Going forward, to improve treatment and enhance early 








Figure 1. Reproduced from 
http://www.ahaf.org/glaucoma/about/understanding/build-up-of-aqueous.html 
Illustration of increased intraocular pressure resulting in damage to the optic nerve, 
a characteristic of glaucoma. 
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While in rare cases neither necessary nor sufficient, monitoring of intraocular 
pressure is one of the best ways for clinicians to assess a patient's risk for glaucoma (Ray 
2003). It is determined by the pressure of aqueous humor, a thick fluid that is produced in 
the ciliary body that flows between the lens and cornea in the anterior segment of the eye. 
It is important in maintaining healthy functioning, through nutrient delivery and waste 
removal. Aqueous humor drains out of the eye through the trabecular meshwork and next 
through Schlemm's canal, after which it rejoins the bloodstream. The coupling of 
production of aqueous humor in the ciliary body and drainage through the trabecular 
meshwork should result in properly balanced intraocular pressure (Ray 2003). Defects in 
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Figure 2 Reproduced from 
http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_
JournalId=3&p_RefId=3140&p_IsPs=Y. Aqueous humor is produced in the ciliary 
body, flows between the lens and cornea and drains out the trabecular meshwork 
and Schlemm’s canal.  
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Glaucoma can be grouped into two categories, late-onset seen in elderly 
individuals which develops late in life, and the much less common developmental form 
which becomes prevalent between birth and the teen years in humans (Gould 2002). Both 
forms exhibit the same retinal ganglion cell death and optic nerve changes as well as 
increased intraocular pressure, suggesting common biological mechanisms are shared 
between the two. Because of the likelihood of shared mechanisms between the two, a 
good understanding of the developmental form of the disease will help in future diagnosis 
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Eye Development 
The anterior segment of the eye, consisting of the cornea, iris, lens, ciliary body, 
trabecular meshwork, and Schlemm's canal, is formed during development through a 
complicated series of events involving predominantly surface ectoderm, neural ectoderm 
and periocular mesenchyme (Gould 2004). The surface ectoderm differentiates into 
corneal epithelium and lens. The neural ectoderm will form the retina as well as the 
epithelia of the iris and ciliary body. The periocular mesenchyme differentiates to form 
many structures of the mature eye including the corneal stroma and endothelium, sclera, 
iris stroma, ciliary muscles, ciliary stroma and trabecular meshwork. (Gould 2004) In 
mice the first trace of what will become the mature eye is observed at approximately 
embryonic day e8.5, located on the anterior part of the forebrain. Shortly thereafter, by 
embryonic day e9.0 the optic pit begins to deepen as the optic vesicles form. These optic 
vesicles must migrate through a layer of mesynchymal tissue until they touch the surface 
ectoderm, which runs along the outside of the developing head (Figure 3A). The surface 
ectoderm and optic vesicle next interact causing formation of the lens placode and retinal 
placode. By e10.5 the neural ectoderm has folded, forming the optic cup (Figure 3B). The 
lens placode differentiates into the lens vesicle, which will stay connected to the surface 
ectoderm until e11.0, when it detaches to allow formation of the cornea to begin (Figure 
3C). Later the optic cup will contribute to the anterior segment, becoming the epithelium 
of the iris and ciliary body. By embryonic day e12.5 the cornea has gone through 
significant development, consisting of two cell layers of surface ectoderm. As the eye 
continues to develop by e14.5 the corneal endothelium is present, and the anterior 
chamber becomes present as a small space opens between the lens and corneal 
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endothelium (Figure 3D). By embryonic day e16.5 the anterior chamber is fully formed. 
Finally between embryonic days e17.0-e19.0, mesenchymal cells migrate to the 
iridocorneal angle to form the trabecular meshwork and Schlemm's canal, important 
drainage structures for maintaining appropriate IOP levels (Figure 3E). (Gould 2004)  
 Throughout the complicated series of events that result in the development of the 
mature eye, the anterior segment maintains a cohesive structure. As the moving parts of 
the anterior segment develop they must stay attached to each other, and to the exterior of 
the head. This implicates one or many important cellular adhesion molecules in the 
development of the anterior segment, which would function to maintain this 
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Fig. 3. Tissue derivations of developing ocular structures.  Moving left to right, A-E. 
A colorscheme is used to represent tissue derivations. For clarity, periocular mesenchyme 
derived tissues are represented by two shades of purple. (A) Neural ectoderm (NE, 
yellow) of the emerging optic vesicle (OV) moves through periocular mesenchyme (M, 
purple) until it reaches the surface ectoderm (SE, pink). (B) The surface ectoderm 
thickens and invaginates to form the lens pit (LP) as the optic vesicle forms the optic cup 
(OC). (C) The lens vesicle (LV) detaches from the surface ectoderm. The surface 
ectoderm becomes the epithelial layer of the future cornea (CE). Periocular mesenchyme 
migrates between the surface ectoderm of the corneal epithelium and the lens vesicle. (D) 
Lens fibers fill the lens vesicle. Mesenchyme that has migrated between the corneal 
epithelium and the lens forms corneal stroma(CS) and corneal endothelium (CN). Neural 
ectoderm in the inner layer of the 
optic cup will form neural retina (NR) and the outer layer will form retinal 
pigmented epithelium (RPE). (E) In the mature eye, the anterior rim of the 
optic cup has moved centrally and forms the epithelia of the iris (IE) and ciliary 
body (CBE). Iris stroma (IS), stroma and muscle of the ciliary body (CB), 
trabecular meshwork (TM) and Schlemm’s canal (SC) are formed from 
periocular mesenchyme. Condensed periocular mesenchyme forms the 
sclera (S) and surrounds the posterior of the eye. 
Reproduced from Gould (2002) 
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Pitx2 and Eye Development  
PITX2 is a paired-like homeodomain transcription factor that has been shown to 
be crucial for normal eye development (Semina 1996) (Gage 1999). Heterozygous 
mutations of PITX2 in humans cause Axenfeld Rieger Syndrome (ARS). ARS symptoms 
include hearing loss, teeth malformations, heart defects, and skeletal malformations as 
well as number of anterior segment defects. These include malformation of the anterior 
chamber angle and drainage structures crucial for maintaining optimal intraocular 
pressure as well as iris hypoplasia, corectopia (asymmetric pupils), polycoria (iris tears), 
iridocorneal tissue adhesions and possible absence of the corneal endothelium and 
Descemet's membrane. As a result of these defects, which lead to increased intraocular 
pressure, 50% of patients with the ARS develop glaucoma, making PITX2 an ideal gene 
to study in a mouse model to further understand the disease. (Lines 2002) 
In mice, Pitx2 expression begins in the neural crest at developmental day e9.5, 
where its activity is crucial for development of the anterior segment. It is also expressed 
in the mesoderm derived periocular mesenchyme from e8.5-e13.5. By e13.5 it is also 
seen in the stroma of the presumptive cornea. After the early stages of development its 
role becomes less significant and by e18.5 it is expressed only in the presumptive iris and 
iridocorneal angle. (Gould 2004) (Gage 2005)  
Studies of Pitx2 global knockout mice (Pitx2 -/-) have confirmed the gene’s 
importance in normal eye development. Not viable at birth due to other developmental 
deficiencies, these embryos show problems with anterior segment development as well as 
problems in development of other parts of the eye. Notably, the cohesiveness that is so 
crucial to normal eye development is gone in several important ways. First, severe 
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agenesis of the anterior segment including the cornea is observed, likely related to the 
elevated IOP seen in human PITX2 mutations. The most notable lack of cohesion during 
eye development in these mutants occurs as the optic cup is displaced towards the 
midline (specifically towards the ventral hypothalamus). With the cohesion between the 
developing eye and outside of the head absent, by developmental day e16.5 an extremely 
foreshortened optic stalk is present, with the eyes located in the center of the head. 
Problems outside of the anterior segment begin with a severely dysmorphic optic stalk, 
suggesting PITX2 may be crucial for normal development of the neurons this structure 
houses. Agenesis of the extraocular muscles is observed as well. (Gage 1999). Pitx2 +/- 
mice, while viable, exhibit a varying degree of anterior segment defects as well including 
corectopia, anisocoria (uneven pupil size), clouded lenses and multiple pupillary 
openings. (Gould 2004) 
Because it was discovered that Pitx2 is expressed in neural crest and not the cells 
making up the optic stalk itself, it was concluded that an essential function of Pitx2 is to 
regulate extrinsic signaling factors that are required for normal development of these 
cells. This original research had implications in optic nerve development as well as in 
treatment of ARS patients with developmental glaucoma. It suggested in addition to the 
elevated intraocular pressure seen in developmental glaucoma that other factors such as 
subtle abnormalities in optic nerve as well as anterior segment development may occur in 
ARS patients leading to the retinal ganglion cell axon damage and death seen in 
glaucoma (Gould 2004) (Gage 1999) (Semina 1996). 
It is in the exploration of further downstream signaling effectors of Pitx2 that will 
be the focus of my thesis. The lack anterior segment cohesion observed in Pitx2 -/- 
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embryos suggests that one or many of these downstream effectors may be cellular 
adhesion molecules, vital for maintaining cohesiveness. To investigate this possibility a 
neural crest specific Beta-catenin knockout strain (Ctnnb1-ncko) will be utilized where 
only a transient burst of Pitx2 expression is seen from developmental days 10-12 in the 
neural crest. This Pitx2 expression pattern is in contrast to the sustained Pitx2 expression 
seen in wild type embryos and complete lack of expression seen in Pitx2 -/- embryos. The 
knockout of Ctnnb1 activity interrupts one of the pathways through which Pitx2 
functions. The transient burst observed in the neural crest is the result of another 
signaling pathway, probably originating with retinoic acid, an upstream effector of Pitx2. 
In the Ctnnb1-ncko strain cohesiveness of the anterior segment is maintained as the eye is 
found in its normal peripheral position attached to the surface ectoderm. In contrast, the 
eye in the Pitx2 -/- strain recedes more and more to the center of the head. Comparison of 
these two strains suggests a mechanism for bonding of structures through cellular 
adhesion that is promoted by the transient burst of Pitx2 observed in the Ctnnb1-ncko 
stain.  
Comparing the optic nerve housing optic stalks of the Pitx2 -/- embryos and 
Ctnnb1-ncko embryos they are both severely deformed but in different ways. In Ctnnb1-
ncko embryos as the eye stays attached to the surface ectoderm the brain stretches out to 
meet the eye resulting in a thick neuroblastic structure as opposed to the normal slender, 
elongated optic nerve seen in wild type. In the Pitx2 -/- embryos the optic nerve is 
deformed in that given the recession of the eye to the center of the head it becomes 
extremely foreshortened. (See Figure 4) 
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Wiltype                                 Pitx2 -/-                                  Ctnnb1-ncko 
 
Figure 4. In Pitx2 -/- embryos the eye migrates to the center of the head. In Ctnnb1-
ncko mutant embryos the eye remains attached to the surface ectoderm while the 
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The observation of the transient burst of Pitx2 expression along with the adhesion 
of the eyes to the surface ectoderm seen in the Ctnnb1-ncko embryos suggests that the 
transient burst of Pitx2 may have downstream targets of cell adhesion genes that cause 
the adhesion of the eye to the surface ectoderm and gross deformation of the optic nerve 
in Ctnnb1-ncko embryos. The primary goal of my research was to determine the nature of 
this adhesion to the surface ectoderm, with the hypothesis that Pitx2 has one or more 
downstream targets of cell adhesion genes. Good candidate genes should show loss of 
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Identification and description of cellular adhesion candidates 
Microarray data from Pitx2 -/- mice suggests a significant number of possible 
cellular adhesion genes that appear to lose expression in PITX2 -/- eyes. Of these genes 
we have selected three best possible downstream cellular adhesion gene targets of the 
transient Pitx2 burst, collagen 8 alpha 2 (Col8a2), fibulin 5 (Fbln5), and dermatopontin 
(Dpt).  
Col8a2 encodes a protein that is a major component of the basement membrane of 
the corneal endothelium, where it forms trimers with other collagens. An important study 
of this gene's role in anterior segment development was performed using a homozygous 
Col8a2G257D mutant human transgene mouse. Deficits in these mice include enlarged 
anterior chambers, thin corneas, and a reduction in size of the corneal epithelium, stroma, 
and Descemet's membrane (Puk 2009). These defects may result in increased intraocular 
pressure, consistent with another finding that these mice exhibit protrusion of the anterior 
segment. Point mutations of the COL8A2 gene in humans have been associated with two 
types of corneal dystrophies, which share features seen in the mutant mouse model 
including thinning of Descemet's membrane and the corneal endothelium. These patients 
also have been observed to be at an increased risk for glaucoma (Puk 2009). These data, 
when considered in conjunction with the microarray data from the Gage lab, implicates 
Col8a2 as a potentially important downstream target of Pitx2. 
Fbln5 encodes a matricellular glycoprotein, important in forming cell-
extracellular matrix interactions through the use of integrins. It is expressed in elastin-
rich tissues, including the eye. Fbln5 knockout mice have been found to exhibit heart 
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vessel defects, aneurisms, and lung defects suggesting a role in vascular development and 
remodeling (Yanagisawa 2009) (Chapman 2010). The eyes of the Fbln5 knockout mice 
have not been fully examined so its role in eye development is not yet adequately 
understood. Its reduced expression has, however, been associated with human Age 
Related Macular Degeneration Type 3, an eye disease in which vision is impaired due to 
damage to the retina. Cutis laxa, a connective tissue disorder in which the skin becomes 
inelastic and hangs from the body in folds, has also been associated with mutant fbln5 
(Jones 2010). Research into eye defects associated with these diseases has provided 
inconsistent results.  
The third potential target of Pitx2 examined was Dpt, an extracellular matrix 
protein that interacts with collagens. It is expressed in mesenchyme and mediates 
collagen fibrillogenesis, the process by which the fibrils of collagen are produced, an 
important aspect of corneal assembly (Takeda 2002). Proper development of the cornea 
depends on the organization and maintenance of the stromal extracellular matrix, which 
must include uniform small collagen fibrils and constant interfibrillar spacing. 
Presumably due to the role of Dpt as a mediator of fibrillogenesis, Dpt knockout mice 
have been found to exhibit corneal defects. These mice on average show a 24% thinner 
corneal stroma compared to wildtype mice as well as disorganization of the fibrils 
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Experimental outline for each gene and hypothesis 
 
 
1) Confirm predicted expression loss in Pitx2 -/- predicted by DNA microarray 
 
It was first necessary to confirm expression loss of Col8a2, Fbln5 and Dpt. 
Utilizing qRT-PCR allowed comparison of relative mRNA levels of these genes in 
wildtype and Pitx2 -/- eyes, giving confirmation to the changes predicted by the 
microarray. Confirmation of expression loss in the Pitx2 -/- eye tissue led to step 2 for 
Col8a2. 
2) Develop riboprobes for each gene that has a confirmed change in expression. 
I developed several riboprobes for Col8a2 using PCR to generate a DNA 
fragment that served as the template for subsequently synthesizing digoxigenin (DIG)-
tagged RNA copies of the DNA template. The DIG labeled probes were then tested using 
RNA in-situ hybridization on paraffin sections of wild type eye tissues to confirm that 
they worked. The presence of annealed probe was detected by immunohistochemistry 
directed against the DIG tags on the probe. Because several probes I designed did not 
adhere to their target mRNAs on wildtype tissue where the mRNAs are known to be 
present, I redesigned new probes until a successful one was developed.  
3) Obtain antibodies for genes found to be present in in-situ experiments for use in 
immunohistochemistry experiments to increase assay specificity. 
To increase specificity of detection, once the Col8a2 transcript was found to be 
present in the developing anterior segment, an antibody was obtained for use in 
immunohistochemistry antibody stainings. 
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4) Determine each gene’s expression pattern in wild type eyes through the relevant time 
window 
The probes and antibodies for each gene were then used in RNA in-situ 
hybridization and antibody staining experiments, respectively, on wildtype eye tissues 
from embryonic days e10.5-14.5 to determine wild type expression patterns. Because 
antibody staining proved to be more effective, the focus of my work was in using this 
technique. The goal was to determine the expression pattern of Col8a2 relative to Pitx2 in 
wild type eyes where we know Pitx2 is expressed in neural crest and is fully functional.  
5) Determine expression differences in wild type vs. Pitx2 -/- and Ctnnb1-ncko eyes 
A combination of RNA in-situ hybridizations and antibody stainings were used on 
e10.5-14.5 embryos to determine relative expression patterns of cell adhesion genes and 
Pitx2 in our two knockout models. One being Pitx2 -/-, where Pitx2 is never expressed 
anywhere and the eyes migrate to the center of the head leading to an extremely 
foreshortened optic nerve by e 16.5. The second knockout model was the Ctnnb1-ncko 
strain, where a transient burst of Pitx2 is seen from e10-12 and the eyes adhere to the 
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Hypothesis and possible outcomes 
We hypothesized two possible outcomes to these experiments. The first is that 
Pitx2 directly activates one or more cellular adhesion genes, which contributes adherence 
of the optic cup to the surface ectoderm during development. In this scenario the cellular 
adhesion gene would turn on after Pitx2 expression begins in the same cells in wild type 
eyes and will not be expressed at all in the Pitx2 -/- eyes. We would expect to see 
expression of the cellular adhesion gene after the transient burst of Pitx2 expression in the 
Ctnnb1-ncko eyes. The other possible outcome is that Pitx2 is required to maintain the 
expression of the cell adhesion gene(s). In this scenario, the cell adhesion gene will be on 
before and maintained after expression of Pitx2 in the wild type and Ctnnb1-ncko eyes. It 
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Materials and methods 
Mouse Husbandry 
Timed pregnant breeding cages were set up to generate embryos for Pitx2 -/-, 
Ctnnb1-ncko, and Pitx2 +/+ embryos. Females were monitored each day for copulation 
plugs at 12 pm. The day a plug was found corresponds to day embryonic development 
day e0.5. Various litters were harvested between days e10.5-e14.5. Pregnant females 
were euthanized using cervical dislocation, after which embryos were immediately 
harvested and processed. Some of the embryos used for the experiments were generated 
specifically for this project, while others were harvested and processed at an earlier date.  
Embryo fixing and sectioning 
After harvesting, embryos were fixed in 4% PFA, which was followed by a wash 
in PBS and dehydration through an ethanol gradient after which they were embedded in 
paraffin in preparation for sectioning. Embryos were sectioned using a microtome 
producing tissue sections of 7 microns in thickness. These sections were mounted onto 
slides on a hot plate and dried overnight in an incubator. 
Generation of PCR primers for qRT-PCR and in-situ hybridization templates 
Complete mRNA sequences for each gene of interest were obtained from the 
MGI- Mouse Genome Informatics website at http://www.informatics.jax.org. Next, the 
Primer3 program at http://frodo.wi.mit.edu/primer3/ was used to develop two sets of 
primers for each gene, one for use in qRT-PCR experiments and one for use in the 
generation of an in-situ hybridization probe. The in-situ hybridization primers required 
further modification while the qRT-PCR primers did not. To each reverse primer of an 
in-situ hybridization set a T7 promoter sequence was added to facilitate T7 RNA 
	   21	  
polymerase binding. To test the primers and determine their optimal annealing 
temperatures gradient PCR experiments were performed with annealing temperatures 
ranging from 55-70 degrees Celsius.  
qRT-PCR experiments  
qRT-PCR experiments were used to confirm expression changes between e12.5 
wildtype and e12.5 Pitx2 -/- cDNA and e14.5 wildtype and Pitx2 -/- cDNA. Experiments 
were run and analyzed by a iCycler PCR machine, using CyBr green reaction mix. 
Generation of in-situ hybridization probes 
In-situ hybridization probes were generated from amplifying a DNA template. 
cDNA templates were used for those primers which were designed across introns. After 
the PCR was complete, a small portion of the reaction mix was run on an agarose gel to 
confirm successful amplification. Next the product was purified using QIAquick PCR 
cleanup. Integrity of this purified DNA product was confirmed in two ways. First, a 
Nanodrop machine was used to check the concentration of the product. If the product was 
found to be sufficiently concentrated (above 40 ng/ul of DNA) it was next sequenced at 
the University of Michigan DNA Sequencing Core to confirm its identity. 
Once found to be sufficiently concentrated and to be the proper sequence, the purified 
DNA product was used to generate a digoxigenin (DIG)-labeled riboprobe. A reaction 
mix was created with 500 ng of this template along with T7 RNA polymerase, which 
could recognize the T7 binding site designed into the DNA sequence. The RNA product 
obtained from this reaction was purified using an RNeasy kit and protocol. Finally before 
being tested on tissue sections the purified product was dot blotted on a nylon membrane 
to quantify its strength.  
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In-situ hybridization 
During the first day of the hybridization RNAse free conditions were maintained. 
First sections were dewaxed in xylene, followed by rehydration through a gradient of 
ethanol washes and DEPC-treated H2O and next DEPC-PBS. The sections were then 
treated with 100 mM Glycine in DEPC-PBS followed by 0.3% Triton-X in DEPC-PBS. 
Next the sections were washed in DEPC-PBS to remove remnants of the previous 
washes. The sections were then incubated at 37 degrees Celsius in a 15 µg/ml of 
proteinase K in proteinase K buffer (100 mM Tris•HCl, 50 mM EDTA, pH 8.0) to 
permeabalize the tissue allowing reagents better access to the transcripts. Next the slides 
were washed briefly in DEPC-H2O, followed by fixing in 4% paraformaldehyde. 
Following fixation, the slides were then washed with DEPC-PBS and next were 
acetylated in TEA/acetic anhydride to neutralize positive charge and reduce non-specific 
background signal. Next, while the slides were washed in DEPC-PBS the probes were 
denatured at 95 degrees Celsius and then applied to the sections and incubated overnight 
at temperatures ranging from 50 to 60 degrees Celsius.  
During the second day, RNAse free conditions were no longer required. To begin 
this day the sections were washed with 50% Formamide/0.5X diluted in H2O at the 
overnight hybridization temperature to remove any remaining non-specifically bound 
probe. This was followed by a wash of 0.5X SSC. Next the slides were incubated in a 
humidified tupperware box with antibody blocking solution, followed by an antibody to 
digoxigenin diluted in this solution. Next, alkaline phospatase was used to label the 
antibody during incubation. Following this were washes of PBS and a chromagen buffer, 
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after which an NBT/BCIP solution diluted in chromagen was applied to the slides for 24-
48 hours during which time the alkaline phospatase used to label the antibody to 
digoxigenin underwent an enzymatic reaction producing a purple stain. After this stain 
had adequately developed the slides were washed with PBS, fixed in 4% 
paraformaldehyde, and then mounted with pro-long gold under coverslips.  
Antibody staining 
Col8a2 antibodies were obtained from Paul Davis in New Zealand. Tissues used 
in antibody stainings were first dewaxed in Xylene, and next rehydrated in 100% and 
95% ethanol washes, followed by washes in PBST to remove traces of ethanol. Next the 
tissues were boiled in 0.1 M citric acid, to expose epitopes necessary for antibody 
binding. After further PBST washes, the sections were washed in 3% H2O2 to quench 
endogenous peroxidases. Left unquenched these peroxidases may increase non-specific 
background signal. An image iT incubation was next utilized to enhance the quality of 
the photographs to be taken at the conclusion of the experiment. To finish the first day of 
the experiment, the sections were incubated in TSA block followed by an overnight 
incubation with the primary Col8a2 antibody diluted in TSA block. The optimal primary 
antibody dilution was found to be 1:6400. Day two of the experiment began with an 
incubation of a secondary antibody directed against the rabbit epitopes of the first 
antibody. Next the slides were incubated with a tertiary reagent, streptavidin horseradish 
peroxidase (SA-HRP), directed against the secondary antibody, to label the proteins for 
fluorescent detection. Finally the sections were incubated with a mixture of flourophores 
and a H2O2 dilution that catalyzes a reaction between the flourophores and SA-HRP, 
producing fluorescently labeled protein.  
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Image analysis and photography 
Tissues stained with the in-situ hybridization protocol were imaged under bright-
field microscopy. Tissues stained with the antibody staining protocol were imaged with 
fluorescent microscopy. All photographs were taken using the Nikon ACT-1 program and 






















 qRT-PCR experiments were performed to compare relative levels of transcripts of 
interest in wildtype and Pitx2 -/- eyes at both e12.5 and e14.5 developmental time points. 
These experiments were performed to examine the fold change of transcript levels of 
Col8a2, Dpt, and Fbln5. (See graphs 1 and 2) 
 At e12.5 a decrease in transcript levels was observed in all three genes of interest. 
Col8a2 exhibited a 0.389 fold change in Pitx2 -/- as compared to wildtype, Fbln5 
exhibited a 0.773 fold change and Dpt exhibited a 0.765 fold change. A paired T-test of 
the data was performed which showed only the fold change observed in Col8a2 levels to 
be statistically significant, giving a P value of .0275. The fold changes of Fbln5 and Dpt 
levels were not statistically significant, giving P values of .432 and .577, respectively. 
At e14.5 a decrease in transcript levels was observed in all three genes of interest 
as well. Col8a2 exhibited a 0.526 fold change in Pitx2 -/- eyes as compared to wildtype, 
Fbln5 exhibited a 0.620 fold change and Dpt exhibited a 0.709 fold change. A paired T-
test found the Col8a2 fold change to be very near statistical significance, giving a P value 
of .112. The fold changes observed for Fbln5 and Dpt were also not statistically 
significant at .144 and .322, respectively.   
These results confirmed that Col8a2 levels are indeed decreased at e12.5 in Pitx2 
-/- eyes, and probably in e14.5 Pitx2 -/- eyes, however the results at e14.5 were not 
statistically significant. Fbln5 and Dpt levels may be decreased, however as these results 
lacked statistical significance their decrease was not confirmed.  
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Because Col8a2 levels were confirmed as affected by the loss of Pitx2, while Dpt and 
Fbln5 were not, Col8a2 was singled out as the gene I would further investigate through 
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Graph 1. At e12.5 a decrease in transcript levels was observed in all three genes of 
intersest. Col8a2 exhibited a 0.389 fold change in Pitx2 -/- as compared to wildtype, 
Fbln5 exhibited a 0.773 fold change and Dpt exhibited a 0.765 fold change. A paired 
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Graph 2. At e14.5 a decrease in transcript levels was observed in all three genes of 
interest as well. Col8a2 exhibited a 0.526 fold change in Pitx2 -/- eyes as compared to 
wildtype, Fbln5 exhibited a 0.620 fold change and Dpt exhibited a 0.709 fold change. 
In these experiments none of the fold changes were found to be statistically 
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Col8a2 in-situ hybridization results 
After confirmation of a change in Col8a2 levels in Pitx2 -/- eyes, an in-situ 
hybridization probe was developed to detect the transcript in embryonic eye sections. The 
probe was tested extensively on e10.5- e14.5 embryos and was found to only be effective 
on e14.5 samples. When functioning properly, it gave very specific signal in the 
developing cornea. (See Figure 5) Detection of transcripts was very inconsistent from 
slide to slide and experiment to experiment. Because of the inconsistency with which the 
probe proved to function, to further examine Col8a2 expression an antibody to the 
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 Figure 5. Col8a2 expression in e14.5 wild type eyes. (A) Col8a2 expression (denoted 
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Col8a2 Immunostaining Results 
 After localizing the location of Col8a2 transcripts in the developing mouse eye, 
two antibodies against the COL8A2 protein were obtained from Paul Davis and used to 
further examine its expression. Each of the antibodies was developed against the 
COL8A2 protein, however, in different rabbits. The two antibodies are referred to as 
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Col8a2 expression during the relevant time window in wildtype eyes 
 First, it was necessary to establish the expression pattern of Col8a2 in wildtype 
eyes from e12.5-e14.5. In e12.5 eyes Col8a2 appears to be expressed in the developing 
cornea. COL8A2 M and COL8A2 S stain slightly differently at e12.5 with S giving a 
slightly broader and stronger signal (Figure 6A, B). Similar results were observed at 
e13.5 where Col8a2 again appears to be expressed in the developing cornea. Again, 
COL8A2 S gives a slightly broader and stronger signal. COL8A2 M gives more signal in 
epithelial cells (Figure 6C, D). Finally at e14.5, again Col8a2 appears to be expressed in 
the developing cornea. At e14.5 COL8A2 M gives the stronger single staining the anterior 
portion of the cornea (Fig 6F). COL8A2 S on the other hand gives a weaker signal in the 
posterior portion of the cornea (Fig 6E). 
After testing the two antibodies across the relevant developmental time points it 
became clear that they stain somewhat differently. However, both stain the developing 
cornea, as expected from my in-situ results. From this evidence their stain appears to be 
specific, the two antibodies may simply be recognizing different forms or different parts 
of the COL8A2 protein. As there are multiple splice variants of the COL8A2 protein the 
possibility that the two antibodies recognize different forms of the protein seems likely. 
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Figure 6. Col8a2 expression in wildtype eyes. Col8a2 expression is shown in red, 
DAPI staining is in blue. Col8a2 expression is denoted with *.  (A-F) Col8a2 appears 
to be expressed in the developing cornea from developmental time points e12.5-
e14.5. Antibody dilution 1:6400. 
	   34	  
Col8a2 expression in Pitx2 -/- eyes mutant 
After localizing COL8A2 in the developing cornea the next step was to determine 
the extent to which it is expressed in Pitx2 -/- embryos. As in the wildtype experiments, 
COL8A2 M and COL8A2 S were found to exhibit similar staining patterns. The 
experiments could only be performed on e13.5 and e14.5 Pitx2 -/- embryos because e12.5 
Pitx2- /- embryos were not available. At both e13.5 and e14.5 Col8a2 expression was 
absent from the mutant eyes in the area where the cornea should have formed (see figure 
7 and 8 B-D, F-H). Very little Col8a2 expression is seen in these mutants, and that which 
is observed is likely non-specific background. Both COL8A2 S signal and COL8A2 M 
signal disappears in the same manner, providing further evidence that both specifically 
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Figure 7. COL8A2 M expression in Pitx2 +/+ and Pitx2 -/- eyes at e13.5 and e14.5. 
Col8a2 in red, DAPI in blue. (A) Wildtype control. (B) e13.5 -/- DAPI only. (C) 
Col8a2 only. (D) Merge.  The area in which the cornea should have developed is 
denoted with *. Col8a2 expression is largely absent in this area. (E) e14.5 wildtype 
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control. (F) e14.5 -/- DAPI only. (G) Col8a2 only. (H) Merge. The area in which the 
cornea would have been expected to develop is denoted with *. Col8a2 expression is 
largely absent in this area. 
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Figure 8. COL8A2 S expression in Pitx2 +/+ and Pitx2 -/- eyes at e13.5 and e14.5. 
Col8a2 in red, DAPI in blue. (A) Wildtype control. Col8a2 expression is seen in the 
developing cornea. (B) e13.5 -/- DAPI only. (C) Col8a2 only. (D) Merge.  The area in 
which the cornea would have been expected to develop is denoted with *. Col8a2 
expression is largely absent in this area. (E) e14.5 wildtype control. (F) e14.5 -/- 
DAPI only. (G) Col8a2 only. (H) Merge. The area in which the cornea should have 
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The experiment was later repeated on an additional e14.5 Pitx2 -/- mutant, which 
showed a similar staining pattern. COL8A2 M and COL8A2 S signal is largely absent in 
the area where the cornea would have been expected to develop. The signal that is present 
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Figure 9. Col8a2 expression e14.5 Pitx2 -/- (A-C) COL8A2 M (A) DAPI only (B) 
Col8a2 only (C) Merge. .  The area in which the cornea would have been expected to 
develop is denoted with *. Col8a2 expression is largely absent in this area. That 
which is present appears to be non-specific background (D-F) COL8A2 S (D) DAPI 
Only (E) Col8a2 only (F) Merge. The area in which the cornea developed is denoted 
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Col8a2 expression appears to be down in mutants 
 Comparing wildtype eyes to Pitx2 -/- eyes in these experiments, Col8a2 levels 
appear to be decreased in the mutants. As the eye recedes more towards the center of the 
developing brain, Col8a2 staining in the area where the cornea would have developed is 
largely absent. This suggests that Col8a2 may indeed have the function of adhering the 
optic cup to the surface ectoderm during developmental and maintaining cohesiveness of 
the anterior segment during development. To further investigate this hypothesis, Col8a2 
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Col8a2 expression in e12.5 Ctnnb1-ncko mutants 
 The next step was to determine if Col8a2 expression is observed in Ctnnb1-ncko 
mice, potentially contributing to the rescuing of the proper eye placement.  phenotype. 
Unfortunately, high levels of background signal, insufficient number of cells in the 
anterior segment, and highly fragile sections plagued these experiments. See Figure 10.  
These problems made Col8a2 expression in e12.5 Ctnnb1-ncko embryos very 
difficult to analyze for several reasons. First, the small number of cells in the developing 
cornea made for a very small population of cells that can show signal. Second, because 
the eyes of these sections were very fragile, they often became damaged during the 
staining procedure (Figure 10D, F, G, H). Third, when signal was observed it appeared to 
be non-specific background signal (Figure 10C, E, G). After repeating the experiment 
several times, results at e12.5 remained inconclusive.  
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Figure 10. Col8a2 expression in e12.5 Ctnnb1-ncko mutants. DAPI shown in blue, 
Col8a2 shown in red. Potentially non-specific background signal is denoted with *. 
Damage to sections is denoted with d. (A-B) e12.5 wildtype control. (C-D) Ctnnb1-
ncko mutant #1: Some staining is observed in the developing cornea, however it may 
be non-specific. Damage occurred in D. (E-F) Ctnnb1-ncko mutant #2: Again, 
Col8a2 signal is present, however it appears to be somewhat non-specific. (G-H) 
Ctnnb1-ncko mutant #3: Again damage to sections plagued these results. Signal 
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Col8a2 expression in e14.5 Ctnnb1-ncko mutants 
 After e12.5 Ctnnb1-ncko results proved inconclusive, I moved to e14.5 embryos 
to test Col8a2 expression. In Ctnnb1-ncko mutants, correct eye placement is rescued, as 
the eye remains as a cohesive unit during development and adheres to the surface 
ectoderm. In these mutants COL8A2 M and COL8A2 S expression is consistently seen in 
an area where the cornea seems likely to have developed. The signal is often less robust 
than in wildtype, and more randomly located. In some mutants who seem to have 
developed a somewhat normal eye, it highly resembles the stain seen in a normally 
developing cornea (Figure 11 D-F). In other mutants in which the eye mutation is more 
severe, the stain is less robust and often more limited in expression (Figure 11C, G-H) 
Despite these differences, each Ctnnb1-ncko mutant observed gave some type of signal in 
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Figure 11. Col8a2 expression in e14.5 Ctnnb1-ncko mutants. Col8a2 in red, DAPI in 
blue. Col8a2 expression is denoted with * (A-B) Wildtype controls: Col8a2 is 
observed in the developing cornea. (C-D) Ctnnb1-ncko mutant #1: Mutant #1 has 
developed one eye which appears similar to a wildtype eye (D) and one eye which is 
more deformed (C). Col8a2 expression is present in both but highly resembles 
wildtype in the more normal eye. (E-F) Ctnnb1-ncko mutant #2. Col8a2 expression 
highly resembles wildtype expression. (G-H) Ctnnb1-ncko mutant #3: The eyes are 
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Next, I repeated this experiment to further verify the Col8a2 expression observed 
in these mutants is specific and reproducible. This experiment gave similar results. All 
Ctnnb1-ncko mutants gave some signal in the developing anterior segment. In some 
mutants this signal highly resembled the pattern observed in a wildtype cornea (Figure 12 
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Figure 12. Col8a2 expression in e14.5 Ctnnb1-ncko mutants. Col8a2 in red, DAPI in 
blue. Col8a2 expression is denoted with * (A-B) Wildtype controls: Col8a2 is 
observed in the developing cornea. (C-D) Ctnnb1-ncko mutant #1: Col8a2 is 
expressed in a location where a cornea should have developed (C).  Expression is 
close to wildtype expression (D). (E-F) Both COL8A2 M and COL8A2 S stain in a 
pattern very similar to wildtype. (G-H) Col8a2 expression is observed, however it is 
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Col8a2 expression is restored in e14.5 Ctnnb1-ncko mutants 
 Analyzing the expression of Col8a2 in these embryos, it reappears in the area of 
the cornea by e14.5. The absence of expression in Pitx2 -/- embryos at this time point 
suggests Col8a2 may have some function in adhering the optic cup to the surface 
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Discussion 
 I have found that the COL8A2 protein is expressed in the developing mouse 
cornea from e12.5-e14.5. It is most strongly at expressed at e14.5. qRT-PCR results first 
showed this expression is decreased in a Pitx2 -/- mutant. In antibody staining 
experiments, Col8a2 is not expressed in the area where the cornea should have formed. 
Cohesiveness of the anterior segment is lost as the eye migrates towards the center of the 
developing mouse brain. At e14.5 in a Ctnnb1-ncko mutant, where cohesiveness of the 
anterior segment during development is rescued, Col8a2 is again expressed in an area 
where the cornea would be expected to develop. These results suggest that Col8a2 may 
contribute to the cohesive development of the anterior segment, and may be important for 
normal corneal development. It appears that Col8a2 may be activated by Pitx2, as 
hypothesized, however a direct link has not been established. However, Col8a2 has held 
up as a gene that is important for cohesiveness of the developing anterior segment. 
Temporally, it remains unclear from my work when Col8a2 is activated relative to Pitx2 
because I was only able to monitor Col8a2 expression between e12.5-e14.5.  
 Throughout my research, I encountered several difficulties. First, the data I 
collected for Fbln5 and Dpt in qRT-PCR experiments did not prove to be statistically 
significant. Although expression of these genes appeared altered at both e12.5 and e14.5 
in a Pitx2 -/- mutant, these results are meaningless without statistical significance. If 
these genes were to be investigated again in the future, a higher number of samples would 
be important for ensuring more reliable results. Due to constraints on time as well as 
resources, only one Pitx2 -/- mutant was examined at both e12.5 and e14.5 in qRT-PCR. 
Second, in-situ hybridizations experiments proved very unreliable in monitoring 
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expression of Col8a2. Even after sequencing of the riboprobe to confirm its identity as 
well as localization of Col8a2 in the cornea with antibody stainings, in-situ 
hybridizations still failed to reliably detect the Col8a2 transcripts. It is possible that 
problems with the in-situ hybridization protocol I used contributed to these difficulties. 
Differences in annealing temperature, reagent concentrations, and incubation time all 
must be controlled and established for each new probe that is developed. While I 
performed many experiments to establish these parameters for my Col8a2 probe, it is 
possible more would have been necessary to achieve an optimal protocol. This 
explanation seems especially plausible given the sporadic nature of the probe’s 
effectiveness. Another possibility for my difficulty in localizing Col8a2 transcripts is that 
the transcripts could be short lived in comparison to the COL8A2 protein. It is possible 
that relatively short-lived Col8a2 transcripts give rise to long-lived COL8A2 protein, 
causing an insufficient number of transcripts in the cornea for detection. This would 
explain why antibody stainings, which recognize proteins, were more effective in 
monitoring Col8a2 expression. A third problem I encountered was the slight differences 
in staining pattern exhibited by my two antibodies COL8A2 M and COL8A2 S. Slight 
variations between results from these two antibodies is seen throughout my results. 
However, I am confident that both antibodies specifically recognize the COL8A2 protein 
for several reasons. First, both antibodies gave signal in the same area as my riboprobe 
signal during in-situ hybridizations, when it functioned properly. Second, signal from 
both antibodies showed the same behavior as it disappeared in Pitx2 -/- mutants and 
reappeared in similar areas in Ctnnb1-ncko mutants. It seems likely that the two 
antibodies may simply recognize different forms or parts of COL8A2. 
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 At this time, the relationship between Col8a2 and Pitx2 is still somewhat unclear. 
The evidence I have provided suggests that Col8a2 expression may rely on Pitx2 
activation, however the link has not been established directly. My localization of Col8a2 
in the developing cornea supports previous findings that Col8a2 mutations have been 
observed in corneal dystrophies in humans (Puk 2009). Human Col8a2 patients have also 
been observed to be at a higher risk for glaucoma (Puk 2009). The potential relationship I 
have established between Col8a2 and Pitx2 supports this finding as well, as Pitx2 is a 
gene which is also known to increase risk for glaucoma in humans. Finally, my work has 
begun to elucidate further downstream effectors of Pitx2 in normal eye developmental. 
Evidence for Col8a2 as a downstream effector of Pitx2 is high, while Dpt and Fbln5 
remain open as possibilities to be further investigated. Further work into the relationship 
of Pitx2 and Col8a2 will help to further elucidate their connection, as well as the 
mechanisms through which Col8a2 may maintain cohesiveness of the anterior segment 
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